Omron's (TYO:6645) subsidiary Omron Healthcare completed its tender offer for Matsuya R&D (TYO:7317) on June 15, acquiring 17.6 million shares.
The offer price stood at 1,110 yen per share and 717,600 yen per share option, with the tender period running from May 19 to June 15, according to a Tokyo bourse filing on Tuesday.
The acquisition exceeded the minimum threshold of 11.2 million shares, raising Omron Healthcare's ownership ratio from 14.64% to 95.88%.
Settlement is scheduled to commence on June 19, through Mizuho Securities and Rakuten Securities.
Following the tender, the company intends to acquire all remaining shares and delist Matsuya R&D from the Tokyo Stock Exchange Growth Market.